# Bacterial vesicles-initiated in-situ spray-polymerized coating enables synergistic antibacterial-photothermal functionality for accelerating wound healing

**Authors:** Dan Wang, Shuya Liang, Zhijuan Ai, Qian Kong, Dongming Xing, Zhenping Cao, Zhongmin Geng

PMC · DOI: 10.7150/thno.126844 · Theranostics · 2026-02-11

## TL;DR

A new wound healing coating combines bacterial vesicles and a polymer to fight infection and boost tissue repair using heat from light.

## Contribution

A novel in-situ spray-polymerized coating integrating antibacterial and photothermal functions for wound healing is developed.

## Key findings

- LBEVs-PPy coating effectively inhibits pathogens like S. aureus, E. coli, and S. epidermidis.
- NIR-induced hyperthermia enhances angiogenic regulators VEGFA and ANGPT1 in HUVECs.
- The coating accelerates wound healing in a mouse model through synergistic antibacterial and photothermal effects.

## Abstract

Although microbial therapies can address the harm to beneficial bacteria and microbiome balance caused by traditional antibacterial treatments in skin damage and infection, their pathogenic potential limits clinical application. Bacterial extracellular vesicles (BEVs) offer a safer alternative by targeting microbes and modulating immunity.

Lactobacillus reuteri-derived BEVs (LBEVs) are functionalized with Fe3+ via electrostatic adsorption, and co-sprayed with pyrrole monomers onto wounds to initiate oxidative polymerization and then form conformal polypyrrole coatings (LBEVs-PPy). Thanks to the natural antibacterial activity of LBEVs, the LBEVs-PPy coating could inhibit the growth of pathogens efficiently. Furthermore, the mild hyperthermia induced by PPy's NIR-triggered photothermal activation significantly upregulates the expression of angiogenic regulators.

In vitro, LBEVs effectively inhibited the growth of S. aureus, E. coli, and S. epidermidis, demonstrating potent antibacterial efficacy. Following mild hyperthermia (42 °C for 1 h), HUVECs showed elevated expression of angiogenic regulators, including VEGFA and ANGPT1. This treatment also activates HSP90/p-eNOS pathway in HUVECs, thereby accelerating angiogenesis. In a mouse model of skin damage and infection, LBEVs-PPy coating significantly accelerates wound healing through synergistic mechanisms that integrate the antibacterial activity of LBEVs and the photothermal effect of PPy.

Our research developed an in-situ spray-polymerized coating integrating antibacterial and photothermal modalities, thus presenting a promising biotherapeutic platform for clinical wound management and tissue regeneration.

## Linked entities

- **Genes:** VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], ANGPT1 (angiopoietin 1) [NCBI Gene 284], HSP90AA1 (heat shock protein 90 alpha family class A member 1) [NCBI Gene 3320]
- **Chemicals:** Fe3+ (PubChem CID 29936), pyrrole (PubChem CID 8027), doxorubicin (PubChem CID 31703)
- **Diseases:** infection (MONDO:0005550)
- **Species:** Staphylococcus aureus (taxon 1280), Escherichia coli (taxon 562), Staphylococcus epidermidis (taxon 1282), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Angpt1 (angiopoietin 1) [NCBI Gene 11600] {aka 1110046O21Rik, Ang-1, Ang1}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, Nos3 (nitric oxide synthase 3, endothelial cell) [NCBI Gene 18127] {aka 2310065A03Rik, Nos-3, eNOS, ecNOS}, Blnk (B cell linker) [NCBI Gene 17060] {aka BASH, Bca, Ly-57, Ly57, Lyw-57, SLP-65}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Hsp86-ps1 (heat shock protein 86, pseudogene 1) [NCBI Gene 111058] {aka 86kDa, Hsp86-2, Hsp90}
- **Diseases:** hyperthermia (MESH:D005334), dislocation (MESH:D004204), skin defect (MESH:D012868), bacterial infection (MESH:D001424), LSCM (MESH:D004401), diabetic (MESH:D003920), infected (MESH:D007239), wound infection (MESH:D014946), urinary tract infections (MESH:D014552), cytotoxicity (MESH:D064420), inflammation (MESH:D007249), skin damage (MESH:D012871), bacteria (MESH:C000719206), deaths (MESH:D003643)
- **Chemicals:** isopropyl alcohol (MESH:D019840), copper (MESH:D003300), eosin (MESH:D004801), FT- (MESH:D005641), polydopamine (MESH:C568283), PBS (MESH:D007854), Cyclophosphamide (MESH:D003520), ROS (MESH:D017382), nitric oxide (MESH:D009569), Bicinchoninic acid (MESH:C047117), water (MESH:D014867), pyrrole (MESH:D011758), DCFH-DA (MESH:C029569), Fe (MESH:D007501), lipid (MESH:D008055), reutericyclin (MESH:C416127), GO (MESH:C000628730), PPy (MESH:C067635), 3-HPA (MESH:C047158), carbon (MESH:D002244), 2',7'-Dichlorodihydrofluorescein diacetate (MESH:C110400), agar (MESH:D000362), FeCl3 (MESH:C024555), H&amp;E (MESH:D006371), sodium chloride (MESH:D012965), propidium iodide (MESH:D011419), calcein AM (MESH:C085925), BEVs (-), oxygen (MESH:D010100), Hematoxylin (MESH:D006416), PI (MESH:D010716)
- **Species:** Limosilactobacillus reuteri (species) [taxon 1598], Mus musculus (house mouse, species) [taxon 10090], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Lactobacillus delbrueckii subsp. bulgaricus (subspecies) [taxon 1585], Staphylococcus aureus (species) [taxon 1280], Staphylococcus epidermidis (species) [taxon 1282], Homo sapiens (human, species) [taxon 9606], Escherichia coli (E. coli, species) [taxon 562]
- **Cell lines:** NIH/3T3 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12964136/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12964136/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12964136/full.md

---
Source: https://tomesphere.com/paper/PMC12964136